Si‐Yang Maggie Liu

Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Zhong‐Yi Dong, Wen‐Zhao Zhong, Xu‐Chao Zhang et al. · Clinical Cancer Research · 2016 · 992 citations

Medicine, Immunology, Oncology +17

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

Zhong‐Yi Dong, Jia‐Tao Zhang, Si‐Yang Maggie Liu et al. · OncoImmunology · 2017 · 445 citations · Full text

Life Sciences, Immunology, Oncology +17

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

Hao Sun, Si‐Yang Maggie Liu, Jiaying Zhou et al. · EBioMedicine · 2020 · 251 citations · Full text

Medicine, Molecular Biology, Oncology +17

Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non–Small Cell Lung Cancer

Jia‐Tao Zhang, Si‐Yang Liu, Wei Gao et al. · Cancer Discovery · 2022 · 222 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Isothermal and nonisothermal crystallization kinetics of nylon-11

Si‐Yang Maggie Liu, Yingning Yu, Yi Cui et al. · Journal of Applied Polymer Science · 1998 · 194 citations

Natural Sciences, Materials Engineering, Materials Science +17